| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910922 | Lung Cancer | 2014 | 6 Pages |
Abstract
This study did not meet its primary endpoint of improving PFS by adding ombrabulin to a taxane-platinum regimen for first-line treatment of metastatic NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Joachim von Pawel, Vera Gorbounova, Martin Reck, Dariusz M. Kowalski, Aurore Allard, Mustapha Chadjaa, Augustin Rey, Jaafar Bennouna, Francesco Grossi, DISRUPT Investigators DISRUPT Investigators,